Handelsbanken Fonder’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
10,800
-1,000
| -8% | -$104K | ﹤0.01% | 909 |
|
|
2025
Q1 | $1.38M | Hold |
11,800
| – | – | 0.01% | 810 |
|
|
2024
Q4 | $998K | Sell |
11,800
-500
| -4% | -$42.3K | ﹤0.01% | 965 |
|
|
2024
Q3 | $1.11M | Buy |
12,300
+2,000
| +19% | +$180K | ﹤0.01% | 902 |
|
|
2024
Q2 | $829K | Sell |
10,300
-400
| -4% | -$32.2K | ﹤0.01% | 913 |
|
|
2024
Q1 | $854K | Buy |
10,700
+3,000
| +39% | +$239K | ﹤0.01% | 904 |
|
|
2023
Q4 | $613K | Buy |
7,700
+900
| +13% | +$71.6K | ﹤0.01% | 1041 |
|
|
2023
Q3 | $475K | Buy |
6,800
+600
| +10% | +$41.9K | ﹤0.01% | 1076 |
|
|
2023
Q2 | $446K | Buy |
6,200
+600
| +11% | +$43.2K | ﹤0.01% | 1129 |
|
|
2023
Q1 | $345K | Buy |
5,600
+1,400
| +33% | +$86.3K | ﹤0.01% | 1209 |
|
|
2022
Q4 | $324K | Sell |
4,200
-2,300
| -35% | -$177K | ﹤0.01% | 1201 |
|
|
2022
Q3 | $290K | Hold |
6,500
| – | – | ﹤0.01% | 1268 |
|
|
2022
Q2 | $249K | Sell |
6,500
-1,000
| -13% | -$38.3K | ﹤0.01% | 1426 |
|
|
2022
Q1 | $310K | Hold |
7,500
| – | – | ﹤0.01% | 1500 |
|
|
2021
Q4 | $283K | Buy |
7,500
+1,300
| +21% | +$49.1K | ﹤0.01% | 1627 |
|
|
2021
Q3 | $204K | Hold |
6,200
| – | – | ﹤0.01% | 1654 |
|
|
2021
Q2 | $418K | Buy |
6,200
+200
| +3% | +$13.5K | ﹤0.01% | 1506 |
|
|
2021
Q1 | $340K | Hold |
6,000
| – | – | ﹤0.01% | 1399 |
|
|
2020
Q4 | $489K | Hold |
6,000
| – | – | ﹤0.01% | 1172 |
|
|
2020
Q3 | $428K | Hold |
6,000
| – | – | ﹤0.01% | 1067 |
|
|
2020
Q2 | $494K | Buy |
+6,000
| New | +$494K | ﹤0.01% | 966 |
|